NCT05872217

Brief Summary

The VRapeutic (Full-immersive game-based therapy) is new therapeutic Egyptian software. It has the potential to provide intensive, repetitive, and task-oriented training. It may increase children's motivation, enjoyment, active social participation. Children with UCP may experience varieties of associated health conditions as difficulty of movement, instability of postural balance, difficulty of motor planning and control which impact on UE function.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 14, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 24, 2023

Completed
8 days until next milestone

Study Start

First participant enrolled

June 1, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
Last Updated

May 24, 2023

Status Verified

May 1, 2023

Enrollment Period

7 months

First QC Date

May 14, 2023

Last Update Submit

May 14, 2023

Conditions

Keywords

virtual realitycerebralpalsy

Outcome Measures

Primary Outcomes (2)

  • rang of motion

    The IMU sensors will be used to detect changes in angular displacement of child arm, forearm (which allow 3D analysis of movements in three planes X.Y.Z), speed and direction. Placement of Sensors: Two sensors will be placed on the affected side, one around the arm distal to shoulder joint and the other around the forearm distal to elbow joint. The third sensor will be placed around the trunk. The child will be in standing position with head in neutral position, trunk erect. The examiner will ask the child to perform functional task in form of (reaching forward toward targets placed on wall in multilevel, hand over head).

    period of treatment will be 2 succssive months

  • • ABILHAND-Kids questionnaire

    will be administrated on an interview basis, the child will be asked to estimate their perception of the level of difficulty that faces during the performance of each activity in the list on a three-point ordinal scale of impossible, difficult, easy. Activities will be presented in random order to avoid any systematic effect. Activities not attempted in the last 3 months are not scored and are entered as missing responses (tick the question mark).

    period of treatment will be 2 succssive months

Study Arms (2)

control group

PLACEBO COMPARATOR

• This group will receive conventional UE therapeutic program for 60 minutes each session including: * Exercises based on neurodevelopment technique . * Gentle manual stretching * Weight-bearing exercises for 10minutes for UE from prone lying, side sitting and quadriped position . * Strengthening exercises for 10 minutes for muscles of UE as push-up from prone lying position, quadriped position, 3 point exercise, walk on hand, climbing, hanging on a bar, squeeze stress balls, cutting usescissors to strengthen hand . * Goal directed training for 10 minutes the child will practice specific tasks that are needed for everyday life and which they find a challenge like (3 daily tasks as cleaning mirror, dressing and undressing, using pen and ruler to draw shapes, brushing teeth . * Fine motor activities as reach, grasp, carry and release activities.

Other: conventional upper extremity therapeutic program

study group

EXPERIMENTAL

Children in this group will receive the same conventional UE therapeutic program as control group for 60 minutes in addition to virtual reality session using VRapeutic software gaming technology, Archeeko module (figure 3) for 30 min/3 sessions/week for 8 weeks

Other: conventional upper extremity therapeutic programOther: full immersive VRapeutic software gaming technology

Interventions

• This group will receive conventional UE therapeutic program for 60 minutes each session including: * Exercises based on neurodevelopment technique . * Gentle manual stretching for tight muscles of the affected UE from proximal to distal segments for 5minutes. * Weight-bearing exercises for 10minutes for UE from prone lying, side sitting and quadriped position. * Strengthening exercises for 10 minutes for muscles of UE as push-up from prone lying position, quadriped position, 3 point exercise, walk on hand, climbing, hanging on a bar, squeeze stress balls, cutting usescissors to strengthen hand . * Goal directed training for 10 minutes the child will practice specific tasks that are needed for everyday life and which they find a challenge like (3 daily tasks as cleaning mirror, dressing and undressing, using pen and ruler to draw shapes, brushing teeth . * Fine motor activities as reach, grasp, carry and release activities.

control groupstudy group

• Children in this group will receive the same conventional UE therapeutic program as control group for 60 minutes in addition to virtual reality session using VRapeutic software gaming technology, Archeeko module (figure 3) for 30 min/3 sessions/week for 8 weeks

study group

Eligibility Criteria

Age6 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Their ages will range from of 6 to 10 years.
  • Both genders will be included.
  • Their degree of spasticity will range from 1 to 1+ according to the Modified Ashworth Scale (Meseguer et al., 2018).
  • Their motor function will be at level I according to Gross Motor Function Classification System (Palisano et al., 2008).
  • They will be able to understand and follow the instructions.

You may not qualify if:

  • Children will be excluded from the study if they have any of the following criteria:
  • Epilepsy.
  • Visual or hearing problems.
  • Musculoskeletal fixed deformity in upper limbs, lower limbs or spine.
  • Orthopedic surgery on the involved UE.
  • Botulinum toxin therapy for the affected UE within the past 6 months or within the study period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Faculty of Physical Therapy

Giza, 12662, Egypt

Location

Faculty of Physical Therapy

Giza, 12662, Egypt

Location

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Eman I Elhadidy

    Cairo University

    STUDY CHAIR
  • Maya G Abd elwahab

    Cairo University

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
A prospective randomized controlled trial of pre-post study design with two months follow-up evaluation will be used.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: intervention Control Group: Children in this group will receive conventional UE therapeutic program for about 60 minutes/3session per week. Children in this group will receive the same conventional UE therapeutic program as control group in addition to virtual reality session using fully-immersive VRapeutic software gaming technology (Archeeko module) for 30 min/3sessions/week for 8 weeks.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator

Study Record Dates

First Submitted

May 14, 2023

First Posted

May 24, 2023

Study Start

June 1, 2023

Primary Completion

January 1, 2024

Study Completion

February 1, 2024

Last Updated

May 24, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations